On a per-share basis, the
The biological medical device maker posted revenue of
For the current quarter ending in December,
The company expects full-year revenue in the range of
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from
Copyright by Automated Insights, Inc. All rights reserved., source